The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting recurrence using a tumor-uninformed ctDNA assay detecting MRD in patients with resected stage II or III colorectal cancer: Subset analysis from the GALAXY study in CIRCULATE-Japan.
 
Yoshiaki Nakamura
Honoraria - Chugai Pharma; Guardant Health AMEA; Merck
Research Funding - Chugai Pharma (Inst); Genomedia (Inst); Guardant Health (Inst); Guardant Health (Inst); Roche (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Kristiyana Kaneva
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Christine Lo
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Daniel Neems
Employment - Tempus Lab LLC
Stock and Other Ownership Interests - Tempus Lab LLC
Travel, Accommodations, Expenses - Tempus Lab LLC
 
Jonathan Freaney
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Consulting or Advisory Role - Agitated Solutions, Inc (I)
Research Funding - Noom (I); Omron Healthcare (I)
Travel, Accommodations, Expenses - Tempus
 
Hala Boulos
No Relationships to Disclose
 
Seung Won Hyun
Employment - Johnson & Johnson/Janssen; Tempus
Leadership - Johnson & Johnson/Janssen; Tempus
 
Eiji Oki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Guardant Health
 
Daisuke Kotani
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Lilly Japan; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Pfizer; Sysmex; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Seagen; Takeda
Research Funding - CMIC (Inst); CMIC (Inst); IQvia (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); SERVIER (Inst); Syneos Health (Inst)
 
Jun Wantanabe
Speakers' Bureau - Johnson & Johnson; Lilly; Medtronic; Takeda
Research Funding - AMCO (Inst); Medtronic (Inst); Stryker (Inst); TERUMO (Inst)
 
Masahito Kotaka
Honoraria - Chugai Pharma; Lilly; Takeda; Yakult Honsha
 
Hideaki Bando
Honoraria - Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst)
 
Ichiro Takemasa
Research Funding - Johnson & Johnson (Inst); Medtronic (Inst); Stryker (Inst)
 
Takeshi Kato
Honoraria - Asahi Kasei; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Takeda
Research Funding - Chugai Pharma
 
Chithra Sangli
Employment - Johnson & Johnson/MedTech
Stock and Other Ownership Interests - ABBVIE/ABBOTT; ABBVIE/ABBOTT; Johnson & Johnson/Janssen; Novo Nordisk; Tempus
 
Richard Blidner
Employment - Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - Listed as an inventor on several patents with Tempus
 
Kate Sasser
Employment - Genmab; Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Genmab
Travel, Accommodations, Expenses - Genmab; Tempus
 
Halla Nimeiri
Employment - Northwestern Medicine; Tempus
Stock and Other Ownership Interests - Abbvie; Roche
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Merck; MSD K.K.; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Sumitomo Corp.
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); FALCO biosystems Ltd. (Inst); Genomedia (Inst); Molecular Health (Inst); MSD (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst)